MET and lung adenocarcinoma: Both in vitro and in vivo, cMet/Siglec15 CAR-T cells showed obvious cytotoxicity against lung adenocarcinoma cells, and at the same time, they could significantly inhibit the growth of lung adenocarcinoma cells in situ and increase the infiltration of T cells in the TME (25).